Combining a multiplex PCR methodology with Next Generation Sequencing (NGS) and a sophisticated bioinformatic analysis, Immunosequencing allows us to profile T-cell and B-cell receptors, providing a complete and accurate view into a patient’s dynamic adaptive immune system view into a patient’s dynamic adaptive immune system.
Immunosequencing has application in different areas, such as immunology, immunotherapy, autoimmunity, transplantation, response to infections, etc. It is a very important tool in research in cancer and other immune-mediated diseases.
ImmunoSeq is designed to study the lymphocyte repertoire with different levels of resolution depending on the sample, number of T cells and the type of study to be performed, allowing great flexibility when designing the experiment and results with exceptional resolution and specificity. Research use only.
T-cell receptor beta (TCRB)
T-cell receptor alpha/delta (TCRA/D)
T-cell receptor gamma (TCRG)
IG kappa/lambda (IGK/L)
ClonoSeq. IVD application for the highly sensitive and precise study and quantification of Minimal Residual Disease in lymphoid diseases. ClonoSEQ harnesses the power of Next Generation Sequencing (NGS) to assist in patient management, allowing assessment of response to treatment, remission status, or possible relapse before clinical symptoms appear.
Both Service and Kit sequencing data is delivered through a secure cloud-based platform with cutting-edge analytic tools designed specifically for immunosequencing data.
Main levels of resolution according to the number of T cells:
SURVEY (2 reactions)
DEEP (6 reactions)
Fill in the form below: